‘Unbiased’ news source? Reuters chairman is top investor and board member of Pfizer
Reuters openly boasts of its 'freedom from bias,' but its chairman’s involvement in Pfizer’s board raises the question: Is that possible?
•
You have not enabled cookies! This site requires cookies to operate properly. Please enable cookies, and refresh your browser for full functionality.